Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Press Releases
Sort By
Newest First
1 / 151
1 / 151
Antibody
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies
Spyre Therapeutics, Inc.
PR-12-24-NI-125
Dec 03, 2024
Inducement Grants
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
Karyopharm Therapeutics Inc.
PR-12-24-NI-124
Dec 03, 2024
CCO
BioDuro-Sundia Appoints Alan Findlater as Chief Commercial Officer to Drive Strategic Growth and Enhance Market Position
BioDuro-Sundia
PR-12-24-NI-123
Dec 03, 2024
Cancer Treatments
Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart Disease
NYU Langone Health
PR-12-24-NI-122
Dec 02, 2024
Acquisition
Ampersand Capital Partners Aquired Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem
Ampersand Capital Partners
PR-12-24-NI-121
Dec 02, 2024
Gene Editing
Gene Editing Market to Hit USD 7.59 Billion by 2029 with 10.2% CAGR | MarketsandMarkets™
MarketsandMarkets™
PR-11-24-NI-104
Nov 21, 2024
oncology
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
SOPHiA Genetics
PR-11-24-NI-120
Nov 21, 2024
Novel Nucleoside
Transposon Therapeutics Acquired a Portfolio of Novel Nucleoside Analogs for Oncology To Enhance Development Pipeline
Transposon Therapeutics
PR-11-24-NI-119
Nov 21, 2024
Hematologic
Skyhawk Therapeutics to Present Preclinical Data of SKY-1214 Combination Treatment in Hematologic Cancers
Skyhawk
PR-11-24-NI-118
Nov 21, 2024
senior management
Vetter Strengthens Senior Management Team for Further Sustainable Growth
Vetter Pharma International GmbH
PR-11-24-NI-117
Nov 21, 2024
Financing
EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics
EQT
PR-11-24-NI-116
Nov 20, 2024
Large Molecule
Bio-Techne and ALZpath Announce Strategic Partnership to Advance Neurdegenerative Disease Research
Bio-Techne Corporation
PR-11-24-NI-109
Nov 20, 2024
Gene Silencing
‘Gene silencing’ therapies market set to boom, says leading biotech
SynaptixBio
PR-11-24-NI-115
Nov 20, 2024
Pancreatic
PCI Pharma Services and ChiRhoClin Partner to Prevent Shortage of Critical Orphan Pancreatic Drug
PCI Pharma Services
PR-11-24-NI-114
Nov 19, 2024
Announcement
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland
Abbott
PR-11-24-NI-108
Nov 19, 2024
Sustainability
Olon Releases its Annual ESG Report
Olon
PR-11-24-NI-110
Nov 19, 2024
CRO
Lindus Health Rolls Out "All-in-One Infectious Disease CRO" Bespoke to Clinical Trials for Infectious Disease Interventions
Lindus Health
PR-11-24-NI-113
Nov 19, 2024
Clinical Trials
Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis
Concerto Biosciences
PR-11-24-NI-112
Nov 19, 2024
biotechnology
Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise
Atlas Venture
PR-11-24-NI-111
Nov 18, 2024
Hematology
Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition
Karyopharm Therapeutics Inc.
PR-11-24-NI-107
Nov 18, 2024
